Instead, its overexpression in cells like ccRCC that show a 30-fold lower level of endogenous EFHD1 compared to HeLa cells was found to significantly reduce [Ca2+]mt (Meng et al, 2023). The gene discussed is EFHD1; the disease is nonpapillary renal cell carcinoma.